Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database

Authors:

Abstract
Breast conservation therapy (BCT) is standard for T1–T2 tumors, but early trials excluded breast cancers > 5 cm. This study was performed to assess patterns and outcomes of BCT for T3 tumors.
Funding Information
  • U.S. Public Health Service (P30 CA006927)

This publication has 20 references indexed in Scilit: